Congo’s Ebola outbreak has most cases in first month of any African outbreak, WHO says

An Ebola outbreak caused by the Bundibugyo strain of the virus was declared in the Ituri Province of the Democratic Republic of the Congo (DRC) on 15 May 202...

What Happened

An Ebola outbreak caused by the Bundibugyo strain of the virus was declared in the Ituri Province of the Democratic Republic of the Congo (DRC) on 15 May 2026, becoming the 17th Ebola outbreak recorded in the DRC.
The WHO declared the outbreak a Public Health Emergency of International Concern (PHEIC) on 16 May 2026 — taking the unprecedented step of doing so without first convening a formal Emergency Committee, citing the scale and speed of spread.
As of 21 June 2026, the DRC Ministry of Health had reported 1,003 confirmed cases and 254 confirmed deaths; Uganda reported 20 confirmed cases and 2 deaths, marking cross-border spread.
The outbreak is the largest first-month caseload of any Ebola outbreak in Africa; outbreak investigation revealed the virus had been circulating for months before the official declaration on 15 May 2026.
The Bundibugyo strain complicates the response because there is no licensed vaccine or approved specific therapeutic against it — the existing Ebola vaccine (rVSV-ZEBOV / Ervebo) and treatments (mAb114, REGN-EB3) were developed for the Zaire strain, which has a different glycoprotein target.
Ituri Province is the most affected area, with 916 confirmed cases from 22 health zones; North Kivu has 84 cases from 11 health zones; South Kivu has 3 cases.

Static Topic Bridges

Ebola Virus Disease — Virology and Species Classification

Ebola Virus Disease (EVD) is caused by viruses belonging to the family Filoviridae, genus Orthoebolavirus. The family is so named because the virions appear as long, filamentous threads under electron microscopy (Latin: "filo" = thread). There are six recognised species of Orthoebolavirus, each named after the geographic location of first discovery.

Six Orthoebolavirus species: (1) Orthoebolavirus zairense (Zaire ebolavirus) — most lethal, CFR up to 90%; (2) Orthoebolavirus sudanense (Sudan ebolavirus); (3) Orthoebolavirus bundibugyoense (Bundibugyo ebolavirus); (4) Orthoebolavirus restonense (Reston ebolavirus — infects primates and pigs, not typically lethal in humans); (5) Orthoebolavirus taïense (Taï Forest ebolavirus); (6) Orthoebolavirus bombaliense (Bombali ebolavirus — discovered 2016 in bats).
Bundibugyo ebolavirus was first identified in Bundibugyo District, western Uganda, during an outbreak from August 2007 to February 2008 (192 suspected cases; case fatality rate ~34%, lower than Zaire strain).
Bundibugyo ebolavirus had caused three outbreaks prior to 2026: Uganda 2007–08, DRC 2012, and now DRC/Uganda 2026.
Transmission: direct contact with bodily fluids of infected persons or animals; no airborne transmission confirmed; natural reservoir believed to be fruit bats (Pteropodidae family).
Incubation period: 2–21 days; persons not infectious during incubation.
No licensed vaccine for Bundibugyo strain; rVSV-ZEBOV (Ervebo, approved by FDA 2019, WHO prequalified 2020) targets only Zaire strain.

Connection to this news: The Bundibugyo strain's different glycoprotein structure compared to Zaire ebolavirus means that the vaccines and monoclonal antibody treatments deployed successfully in the 2018–20 DRC outbreak (which used rVSV-ZEBOV) cannot be directly applied, creating a significant response gap in the current outbreak.

WHO International Health Regulations (IHR) 2005 — PHEIC Declaration

The International Health Regulations (2005) are a legally binding international agreement adopted under Article 21 of the WHO Constitution, entered into force 15 June 2007, with 196 states parties. The IHR establishes the framework for detecting, reporting, and responding to Public Health Emergencies of International Concern (PHEIC).

A PHEIC is defined under IHR Article 1 as "an extraordinary event which is determined to constitute a public health risk to other States through the international spread of disease and to potentially require a coordinated international response."
Under IHR Article 12, the WHO Director-General determines whether an event constitutes a PHEIC, normally after consulting the Emergency Committee convened under Article 48; the 2026 Ebola PHEIC was declared without awaiting the Emergency Committee — an unprecedented procedural departure.
IHR Annex 2 provides a decision instrument with four criteria: (1) serious public health impact; (2) unusual or unexpected; (3) risk of international spread; (4) risk of restrictions on travel or trade.
Countries have core capacities they must develop under IHR — surveillance, laboratories, rapid response, risk communication, points of entry management — structured under 13 core capacity areas.
Post-COVID reforms to IHR were adopted by the World Health Assembly in May 2024 (effective June 2025), including clearer definitions of "pandemic emergency" as a category distinct from PHEIC, and stronger core capacity timelines.
This 2026 outbreak was declared a PHEIC but NOT a "pandemic emergency" under the revised IHR — a distinction that carries different financial and coordination obligations.
India's IHR obligations: India has 196 designated Points of Entry (airports, seaports, land crossings) that must maintain core public health capacities; ICMR and NCDC are the national focal points under IHR.

Connection to this news: The WHO's unprecedented step of declaring PHEIC without convening the Emergency Committee signals the severity of the outbreak and the urgency of international response, while simultaneously testing the limits of the 2024 IHR reforms in practice.

Health Emergency Preparedness and Response (HEPR) Framework

The HEPR (Health Emergency Preparedness, Readiness and Response) framework is the WHO-led architecture for coordinating international responses to health emergencies, distinct from but interlocking with the IHR. It encompasses preparedness (before emergencies), readiness (capacities for rapid deployment), and response (actual emergency operations).

HEPR was operationalised under the ACT-Accelerator partnership during COVID-19 and subsequently institutionalised as a standing WHO framework in 2023.
Key components: GOARN (Global Outbreak Alert and Response Network) — the WHO's primary operational coordination tool for field response; CEPI (Coalition for Epidemic Preparedness Innovations) — funds vaccine R&D for epidemic-prone pathogens (including Ebola variants); GAVI (the Vaccine Alliance) — handles vaccine procurement and deployment.
The Pandemic Fund (formerly CEPI's emergency mechanism, restructured 2023) provides rapid financing for outbreak response in low-income countries.
Marburg virus, Sudan ebolavirus (2022 Uganda outbreak), and Bundibugyo ebolavirus are all on the WHO R&D Blueprint list of priority pathogens — identifying gaps where vaccines/therapeutics do not exist.
WHO R&D Blueprint, launched 2016 after the Ebola West Africa epidemic (2014–16), prioritises research into diseases with epidemic potential but no or insufficient medical countermeasures.

Connection to this news: The absence of a licensed Bundibugyo vaccine is exactly the gap that WHO R&D Blueprint and CEPI were designed to address; the 2026 outbreak is likely to accelerate emergency use authorisation processes for candidate Bundibugyo vaccines currently in development.

India's Public Health Emergency Architecture — ICMR and NCDC

India's preparedness for emerging infectious diseases sits primarily with the Indian Council of Medical Research (ICMR) and the National Centre for Disease Control (NCDC), both of which are the country's IHR national focal points and maintain biosafety level (BSL-4) capabilities for handling filovirus samples.

ICMR (established 1911 as Indian Research Fund Association, renamed 1949): apex body for biomedical and health research; operates the National Institute of Virology (NIV), Pune — India's highest-security BSL-4 virology laboratory capable of handling Ebola-class pathogens.
NCDC, under the Ministry of Health and Family Welfare, is the primary epidemiological surveillance body and the national IHR focal point for notification to WHO.
India has no documented Ebola cases; however, enhanced surveillance at international airports (especially from Africa-originating flights) is standard protocol under the IDSP (Integrated Disease Surveillance Programme) during international PHEICs.
IDSP (launched 2004) operates a "P-form, L-form, S-form" surveillance system across district, state, and central levels; PHEICs trigger the "S-form" (special surveillance) protocol.

Connection to this news: While India has not reported any Ebola cases, the PHEIC declaration triggers India's IHR obligations at Points of Entry, requiring heightened screening and NCDC/ICMR readiness protocols.

Key Facts & Data

Outbreak declared (DRC official declaration): 15 May 2026
PHEIC declared by WHO: 16 May 2026 (without Emergency Committee — unprecedented)
Causative agent: Bundibugyo ebolavirus (Orthoebolavirus bundibugyoense), family Filoviridae
DRC confirmed cases (as of 21 June 2026): 1,003; confirmed deaths: 254
Uganda confirmed cases (as of 22 June 2026): 20; deaths: 2
Most affected province: Ituri (916 cases, 22 health zones); North Kivu (84 cases), South Kivu (3 cases)
This is the 17th Ebola outbreak in the DRC's recorded history
First Bundibugyo strain outbreak: Uganda, August 2007–February 2008 (CFR ~34%)
Prior Bundibugyo outbreaks: Uganda (2007–08), DRC (2012), DRC/Uganda (2026)
Available Ebola vaccine (Ervebo / rVSV-ZEBOV): effective only against Zaire strain; NOT applicable to Bundibugyo
IHR (2005): 196 states parties; entered into force 15 June 2007
IHR 2024 reforms: adopted WHA May 2024; effective June 2025; introduced "pandemic emergency" as distinct category
Ebola incubation period: 2–21 days
WHO R&D Blueprint launched: 2016